company and another listed company with transaction size of 50% or higher and FPI is required to disclose information regarding the acquisition of assets of the Company to the SET, to appoint the

1, which is an acquisition of assets between a listed company and another listed company with transaction size of 50% or higher and FPI is required to disclose information regarding the acquisition of

Assets B.E. 2547 (the “Acquisition and Disposal Rule”). Accordingly, the Company has a duty to disclose the information memorandum of such transactions to the Stock Exchange of Thailand and to send the

Concerning the Acquisition and Disposition of Assets B.E. 2547 (the “Acquisition and Disposal Rule”). Accordingly, the Company has a duty to disclose the information memorandum of such transactions to the

/ Company Tax ID : 0107545000021 (1) To disclose information on the disposal of assets to the Stock Exchange of Thailand; (2) Send letter of notification to shareholders regarding the assets disposition of

of the Company for the 3-month period ending 31 March 2018. As a result, the Company is obliged to seek approval from the Board of Directors and disclose information memorandum to the SET. The details

actions: 2 (1) disclose information on the class 2 transaction to the Stock Exchange of Thailand (the “SET”) pursuant to the Acquisition and Disposition Notifications (as detailed below in item A (GSG

the ASEAN CIS will be disclosed and distributed to investors in Thailand within the same period as having the duty to disclose and distribute such information to investors in Home Jurisdiction. Yes No

ordinary shares of Modern Pharma Company Limited is a subsidiary of the Company, the Company, therefore, has a duty to disclose the transaction information of the Company to the Stock Exchange of Thailand

months which considered as disposition of assets category 2 as size of transaction more than 15% but less than 50% by CEN need to prepare and promptly disclose information to The Stock Exchange of Thailand